Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285087676> ?p ?o ?g. }
- W4285087676 abstract "Abstract The present paper evaluates the photocatalytic degradation ( PCD ) performance of the biofabricated hematite nanoparticles ( α-HNPs ) for the degradation approach of the Cefotaxime ( Cfm ). The optimum pH of the solution to achieve the best PCD was found to be 10.5. The kinetics study for the PCD of the Cfm via α-HNPs has been investigated and the reaction was found to be fellow pseudo-first-order at R 2 = 0.992. The mass loading impact of α-HNPs was investigated and estimated for the maximum degradation of Cfm 0.4 mg/mL. UV–Vis confirmed that α-HNPs had a direct transition bandgap at 3.78 eV at a maximum absorption wavelength of 362 nm with suspension stability for 7 days. The probable mechanism of the Cfm PCD via α-HNPs and the degradation pathway was conducted. The validation of the suspension stability of the α-HNPs (−68.6 ± 11.8 mV) was determined using the zeta potential investigation test. XRD investigation was conducted after Cfm PCD showing an average crystallite size of 27.0 nm. XRD, TEM, SEM, EDX, and FT-IR analyses have been conducted for the α-HNPs before and after Cfm PCD confirming the high efficiency for the reusability of the current biocatalyst α-HNPs for further use. TEM results of the particle sizes of α-HNPs were found at 19.2 ± 4.4 and 20.6 ± 7.4 nm respectively before and after Cfm PCD . The efficiency of the Cfm PCD was found to be 99.1% after 6 h. High potent as an antibacterial agent of α-HNPs was investigated either α-HNPs alone or after its PCD activity against Cfm . The antibacterial activity revealed high sensitivity, especially toward Gram-positive species indicating its promising ability against pathogenic issues. Interestingly, Cfm@α-HNPs showed superior anti-proliferative activity as tested by MTT assay and were able to induce apoptosis in MCF7 and HepG2 cell lines using the flow cytometry technique at 20.7% and 17% respectively. Also, The IC 50 of hydrogen peroxide scavenging was estimated and it was manifested that 635.8 and 665.6 μg/mL of α-HNPs before and after the PCD process of Cfm respectively." @default.
- W4285087676 created "2022-07-14" @default.
- W4285087676 creator A5003740569 @default.
- W4285087676 creator A5020106493 @default.
- W4285087676 creator A5020827010 @default.
- W4285087676 creator A5044222104 @default.
- W4285087676 creator A5053492154 @default.
- W4285087676 creator A5072041110 @default.
- W4285087676 creator A5083033379 @default.
- W4285087676 creator A5085221815 @default.
- W4285087676 date "2022-07-13" @default.
- W4285087676 modified "2023-10-18" @default.
- W4285087676 title "Cefotaxime removal enhancement via bio-nanophotocatalyst α-Fe2O3 using photocatalytic degradation technique and its echo-biomedical applications" @default.
- W4285087676 cites W1700397019 @default.
- W4285087676 cites W1963583644 @default.
- W4285087676 cites W1968262299 @default.
- W4285087676 cites W1977747064 @default.
- W4285087676 cites W1983789627 @default.
- W4285087676 cites W1984710482 @default.
- W4285087676 cites W1993664833 @default.
- W4285087676 cites W1995304732 @default.
- W4285087676 cites W1996191815 @default.
- W4285087676 cites W1996637104 @default.
- W4285087676 cites W1997446721 @default.
- W4285087676 cites W2000082329 @default.
- W4285087676 cites W2017464721 @default.
- W4285087676 cites W2020530692 @default.
- W4285087676 cites W2022841109 @default.
- W4285087676 cites W2023240878 @default.
- W4285087676 cites W2033078592 @default.
- W4285087676 cites W2037766564 @default.
- W4285087676 cites W2039108567 @default.
- W4285087676 cites W2040301915 @default.
- W4285087676 cites W2041729389 @default.
- W4285087676 cites W2044417415 @default.
- W4285087676 cites W2044502066 @default.
- W4285087676 cites W2046179663 @default.
- W4285087676 cites W2047882244 @default.
- W4285087676 cites W2052099337 @default.
- W4285087676 cites W2057603320 @default.
- W4285087676 cites W2059350161 @default.
- W4285087676 cites W2072471831 @default.
- W4285087676 cites W2080079641 @default.
- W4285087676 cites W2086450360 @default.
- W4285087676 cites W2089435231 @default.
- W4285087676 cites W2090990681 @default.
- W4285087676 cites W2112629990 @default.
- W4285087676 cites W2113983279 @default.
- W4285087676 cites W2120055287 @default.
- W4285087676 cites W2145657672 @default.
- W4285087676 cites W2152628887 @default.
- W4285087676 cites W2153528954 @default.
- W4285087676 cites W2161053097 @default.
- W4285087676 cites W2283983369 @default.
- W4285087676 cites W2306949610 @default.
- W4285087676 cites W2513449905 @default.
- W4285087676 cites W2520245248 @default.
- W4285087676 cites W2608923539 @default.
- W4285087676 cites W2626111885 @default.
- W4285087676 cites W2735545726 @default.
- W4285087676 cites W2752672966 @default.
- W4285087676 cites W2753380714 @default.
- W4285087676 cites W2753684829 @default.
- W4285087676 cites W2907124204 @default.
- W4285087676 cites W2913639788 @default.
- W4285087676 cites W2915424403 @default.
- W4285087676 cites W2943891555 @default.
- W4285087676 cites W2954059024 @default.
- W4285087676 cites W2975339546 @default.
- W4285087676 cites W2980124430 @default.
- W4285087676 cites W2989896954 @default.
- W4285087676 cites W2990300559 @default.
- W4285087676 cites W3007453123 @default.
- W4285087676 cites W3008798400 @default.
- W4285087676 cites W3020002710 @default.
- W4285087676 cites W3034844104 @default.
- W4285087676 cites W3035839523 @default.
- W4285087676 cites W3047434459 @default.
- W4285087676 cites W3120594304 @default.
- W4285087676 cites W3127644344 @default.
- W4285087676 cites W3146062358 @default.
- W4285087676 cites W3185646306 @default.
- W4285087676 cites W4200550413 @default.
- W4285087676 cites W4206227777 @default.
- W4285087676 cites W4214564860 @default.
- W4285087676 cites W4220951813 @default.
- W4285087676 doi "https://doi.org/10.1038/s41598-022-14922-3" @default.
- W4285087676 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35831423" @default.
- W4285087676 hasPublicationYear "2022" @default.
- W4285087676 type Work @default.
- W4285087676 citedByCount "17" @default.
- W4285087676 countsByYear W42850876762022 @default.
- W4285087676 countsByYear W42850876762023 @default.
- W4285087676 crossrefType "journal-article" @default.
- W4285087676 hasAuthorship W4285087676A5003740569 @default.
- W4285087676 hasAuthorship W4285087676A5020106493 @default.
- W4285087676 hasAuthorship W4285087676A5020827010 @default.
- W4285087676 hasAuthorship W4285087676A5044222104 @default.
- W4285087676 hasAuthorship W4285087676A5053492154 @default.
- W4285087676 hasAuthorship W4285087676A5072041110 @default.